LATEST NEWS

Novavax and Catalent Announce Closing of Strategic Partnership

 GAITHERSBURG, MD, July 31, 2019: Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene Therapy unit, the leading viral vector development and...

MEDIA & PRESS CONTACT 

Colleen Floreck, Senior Director, Marketing and Communications

+1 443-262-3246 | cfloreck@paragonbioservices.com

JOIN THE CONVERSATION

Follow us on social media:

EVENTS

Come meet us!

BPI East

BioProcess International

September 9 – 12, 2019

Booth 202

Boston, MA

World Vaccine Congress Washington

Cell & Gene Meeting on the Mesa

October 2 – 4, 2019

Carlsbad, CA

ESGCT

ESGCT

October 22 – 25, 2019

Barcelona, Spain

Paragon Bioservices will be attending and or be exhibiting at the following events.

We would be delighted to meet you in person during the show. Contact us to schedule a time to discuss your needs!